T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
AN2 Therapeutics
ANTX
$216M
| $107K | ﹤0.01% |
+22,022
| New | +$94.7K |
|
3127
Information Services Group
III
$245M
| $107K | ﹤0.01% |
25,988
| – | – |
|
3128
Acumen Pharmaceuticals
ABOS
$206M
| $106K | ﹤0.01% |
+39,327
| New | +$97.1K |
|
3129
EverCommerce
EVCM
$1.19B
| $106K | ﹤0.01% |
10,523
| – | – |
|
|
KGEI
3130
Kolibri Global Energy
KGEI
$241M
| $105K | ﹤0.01% |
21,035
+3,336
| +19% | +$17.8K |
|
3131
Resources Connection
RGP
$133M
| $105K | ﹤0.01% |
24,580
-16,412
| -40% | -$68.9K |
|
|
SELF
3132
Global Self Storage
SELF
$58.9M
| $105K | ﹤0.01% |
19,971
| – | – |
|
|
CNTN
3133
Canton Strategic Holdings
CNTN
$176M
| $105K | ﹤0.01% |
+36,908
| New | +$117K |
|
3134
eHealth
EHTH
$29.6M
| $104K | ﹤0.01% |
69,190
-4,146
| -6% | -$6.95K |
|
3135
Crexendo
CXDO
$193M
| $102K | ﹤0.01% |
13,545
| – | – |
|
3136
UNIFI
UFI
$126M
| $101K | ﹤0.01% |
21,091
| – | – |
|
3137
Century Casinos
CNTY
$33.2M
| $100K | ﹤0.01% |
77,933
+18,102
| +30% | +$25.4K |
|
3138
Gyre Therapeutics
GYRE
$737M
| $100K | ﹤0.01% |
+15,031
| New | +$102K |
|
3139
loanDepot
LDI
$264M
| $99K | ﹤0.01% |
78,887
+26,601
| +51% | +$35.9K |
|
3140
1stdibs.com
DIBS
$152M
| $98K | ﹤0.01% |
+19,892
| New | +$95.9K |
|
3141
Kaltura
KLTR
$223M
| $98K | ﹤0.01% |
74,996
+27,039
| +56% | +$36.7K |
|
|
OKUR
3142
OnKure Therapeutics
OKUR
$137M
| $98K | ﹤0.01% |
+21,481
| New | +$92.2K |
|
3143
Lifezone Metals
LZM
$363M
| $97K | ﹤0.01% |
24,778
+6,052
| +32% | +$28.3K |
|
3144
Unicycive Therapeutics
UNCY
$143M
| $95K | ﹤0.01% |
+20,048
| New | +$148K |
|
|
BRCB
3145
Black Rock Coffee Bar Inc
BRCB
$197M
| $95K | ﹤0.01% |
11,421
| – | – |
|
|
AOMR
3146
Angel Oak Mortgage REIT
AOMR
$192M
| $93K | ﹤0.01% |
10,222
| – | – |
|
3147
Alpha Pro Tech
APT
$53.7M
| $90K | ﹤0.01% |
16,000
| – | – |
|
|
VENU
3148
Venu Holding Corp
VENU
$101M
| $90K | ﹤0.01% |
+39,405
| New | +$141K |
|
3149
Comtech Telecommunications
CMTL
$45.8M
| $88K | ﹤0.01% |
41,504
+9,640
| +30% | +$37.1K |
|
|
BZAI
3150
Blaize Holdings
BZAI
$71.2M
| $88K | ﹤0.01% |
63,128
+23,928
| +61% | +$42.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.